Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Stress Marker Aberrations in Multiple Sclerosis: A Meta-Analysis Study
Shu-Yao Zhang, Lue-Ning Gui, Yi-Ying Liu, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Clara Mayer, Lluís Riera‐Ponsati, Sakari Kauppinen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Human serum albumin in neurodegeneration
Sajjad Shojai, S. Rohani, Ali Akbar Moosavi–Movahedi, et al.
Reviews in the Neurosciences (2022) Vol. 33, Iss. 7, pp. 803-817
Closed Access | Times Cited: 32
The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial
Kimia Motlagh Asghari, Neda Dolatkhah, Hormoz Ayromlou, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Oxidative stress in multiple sclerosis—Emerging imaging techniques
Christopher Hollen, Lee E. Neilson, Ramon Barajas, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 17
Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing–Remitting Multiple Sclerosis
Anna Bizoń, Justyna Chojdak-Łukasiewicz, Sławomir Budrewićz, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1638-1638
Open Access | Times Cited: 16
Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics
Nesma A.M. Ghonimi, Khaled A. Elsharkawi, Doaa S.M. Khyal, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 51, pp. 102941-102941
Closed Access | Times Cited: 38
Untargeted Metabolomic Profiling of Cuprizone‐Induced Demyelination in Mouse Corpus Callosum by UPLC‐Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders
Zhijie Zhao, Tongqi Li, Xiaohua Dong, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 34
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Yuri Zilberter, Dennis R. Tabuena, Misha Zilberter
Progress in Neurobiology (2023) Vol. 231, pp. 102539-102539
Open Access | Times Cited: 13
Novel Cell Models to Study Myelin and Microglia Interactions
Marta Santacreu-Vilaseca, Judith Moreno-Magallon, Alba Juanes-Casado, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2179-2179
Open Access
Oxidative Stress Markers in Multiple Sclerosis
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Paula Salgado-Cámara, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6289-6289
Open Access | Times Cited: 4
Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner
Mohamed Reda Fazazi, Prenitha Mercy Ignatius Arokia Doss, Resel Pereira, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The Connection Between Oxidative Stress, Mitochondrial Dysfunction, Iron Metabolism and Microglia in Multiple Sclerosis: A Narrative Review
Simonida Delic, Svetlana Miletić Drakulić, Miloš Stepović, et al.
NeuroSci (2025) Vol. 6, Iss. 1, pp. 23-23
Open Access
Parental smoking before childbirth and multiple sclerosis onset in their child: a case-control study
Sanaz Khodadadi, Sahar Nikkhah Bahrami, Shima Jahani, et al.
Acta Neurologica Belgica (2025)
Closed Access
Integrated Bioinformatics and Experimental Verification to Dissect the Mechanisms and Bioactive Ingredients of Radix Rehmanniae in Treating Multiple Sclerosis
Jing Xie, Meiling Wu, Li Li, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151790-151790
Closed Access
Mushroom Natural Products in Neurodegenerative Disease Drug Discovery
Arjuna Abitbol, Brody Mallard, Evelin Tiralongo, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3938-3938
Open Access | Times Cited: 14
Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
Yan Wang, David Pleasure, Wenbin Deng, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 18
The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants
Panagiotis Theodosis‐Nobelos, Eleni A. Rekka
Molecules (2022) Vol. 27, Iss. 23, pp. 8402-8402
Open Access | Times Cited: 13
Circulatory Indicators of Lipid Peroxidation, the Driver of Ferroptosis, Reflect Differences between Relapsing–Remitting and Progressive Multiple Sclerosis
Ljiljana Stojković, Ana Djordjević, Milan Stefanović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11024-11024
Open Access | Times Cited: 2
Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial
Sara Keramatzadeh, Seyed Ahmad Hosseini, Nastaran Majdinasab, et al.
Nutritional Neuroscience (2024), pp. 1-9
Closed Access | Times Cited: 2
Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study
Paulina Wigner, Angela Dziedzic, Ewelina Synowiec, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
Andrea Burgetová, Petr Dušek, Tomáš Uher, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1365-1365
Open Access | Times Cited: 11
Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system
Steinunn Sara Helgudóttir, Anne Skøttrup Mørkholt, Jacek Lichota, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1437-1445
Open Access | Times Cited: 6
Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1/NF-kB/GFAP signaling pathway.
Tayebeh Noori, Ahmad Reza Dehpour, Seyede Darya Alavi, et al.
PubMed (2023) Vol. 26, Iss. 11, pp. 1272-1282
Closed Access | Times Cited: 5
Oxidative Stress and the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Pathway in Multiple Sclerosis: Focus on Certain Exogenous and Endogenous Nrf2 Activators and Therapeutic Plasma Exchange Modulation
Dimitar Tonev, Albena Momchilova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17223-17223
Open Access | Times Cited: 5
Anti-inflammatory, antioxidant and anti-mitophagy effects of trans sodium crocetinate on experimental autoimmune encephalomyelitis in BALB/C57 mice
Sara Banaeeyeh, Amir Afkhami-Goli, Zahra Moosavi, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 783-801
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top